IN2014CN04326A - - Google Patents

Download PDF

Info

Publication number
IN2014CN04326A
IN2014CN04326A IN4326CHN2014A IN2014CN04326A IN 2014CN04326 A IN2014CN04326 A IN 2014CN04326A IN 4326CHN2014 A IN4326CHN2014 A IN 4326CHN2014A IN 2014CN04326 A IN2014CN04326 A IN 2014CN04326A
Authority
IN
India
Prior art keywords
biomarkers
pregnancy
monitoring
devices
application discloses
Prior art date
Application number
Other languages
English (en)
Inventor
Gregoire Thomas
Robin Tuytten
Piet Moerman
Original Assignee
Pronota Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pronota Nv filed Critical Pronota Nv
Publication of IN2014CN04326A publication Critical patent/IN2014CN04326A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IN4326CHN2014 2011-12-15 2012-12-14 IN2014CN04326A (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161576273P 2011-12-15 2011-12-15
EP11193847 2011-12-15
US201261650145P 2012-05-22 2012-05-22
EP12168955 2012-05-22
PCT/EP2012/075643 WO2013087887A2 (fr) 2011-12-15 2012-12-14 Biomarqueurs et paramètres pour troubles hypertensifs de grossesse

Publications (1)

Publication Number Publication Date
IN2014CN04326A true IN2014CN04326A (fr) 2015-09-04

Family

ID=48613303

Family Applications (1)

Application Number Title Priority Date Filing Date
IN4326CHN2014 IN2014CN04326A (fr) 2011-12-15 2012-12-14

Country Status (10)

Country Link
US (1) US20140349881A1 (fr)
EP (1) EP2791683B1 (fr)
CN (1) CN104136924B (fr)
AU (1) AU2012351504C1 (fr)
BR (1) BR112014014456A2 (fr)
CA (1) CA2859295A1 (fr)
IN (1) IN2014CN04326A (fr)
RU (1) RU2673074C2 (fr)
WO (1) WO2013087887A2 (fr)
ZA (1) ZA201404319B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017051413A1 (fr) * 2015-09-21 2017-03-30 4C Diagnostics Ltd. Moyens de collecte, d'échantillonnage et de diagnostic portant sur des échantillons de selles et procédés associés
CN109073654A (zh) * 2016-04-20 2018-12-21 苏州爱尔迪思生物科技有限公司 用于预测早产的方法和组合物
WO2017197573A1 (fr) * 2016-05-17 2017-11-23 Ldx Prognostics Limited Co. Méthodes et compositions pour fournir une évaluation de la prééclampsie
CN106086182B (zh) * 2016-06-17 2019-06-07 李永旺 Pcyox1蛋白在作为缺血性脑卒中生物标志物中的应用
FR3059550B1 (fr) * 2016-12-01 2020-01-03 Universite De Rouen Normandie Traitement des troubles causes par l'alcoolisation foetale (tcaf)
AU2019218548A1 (en) * 2018-02-09 2020-09-03 Metabolomic Diagnostics Limited Methods of predicting pre term birth from preeclampsia using metabolic and protein biomarkers
RU2691114C1 (ru) * 2018-03-20 2019-06-11 федеральное государственное бюджетное образовательное учреждение высшего образования "Ростовский государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ прогнозирования развития преэклампсии в поздние сроки беременности
CN108776226B (zh) * 2018-04-08 2021-03-19 邓成 晚发型子痫前期快速筛查用试纸和试剂盒
CA3100851A1 (fr) * 2018-05-24 2019-11-28 The University Of Melbourne Biomarqueurs circulatoires pour la sante placentaire ou fƒtale
KR20200049365A (ko) * 2018-10-31 2020-05-08 서울대학교산학협력단 임신성 당뇨 및 임신 중 고혈압 예측을 위한 바이오마커
CN111933216B (zh) * 2019-05-13 2024-02-27 南方医科大学珠江医院 肠道微生物作为子痫前期生物标志物的用途
EP4070113A4 (fr) 2019-12-04 2023-12-20 Biora Therapeutics, Inc. Évaluation de la prééclampsie à l'aide de dosages du facteur de croissance placentaire libre et dissocié
KR102302742B1 (ko) * 2019-12-31 2021-09-15 의료법인 성광의료재단 임신중독증 진단용 바이오마커 조성물 및 이의 용도
KR102233909B1 (ko) * 2020-07-13 2021-03-30 서울대학교산학협력단 임신성 당뇨 및 임신 중 고혈압 예측을 위한 바이오마커
RU2751139C1 (ru) * 2020-12-03 2021-07-08 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт акушерства, гинекологии и репродуктологии имени Д.О. Отта" Способ прогнозирования риска развития преэклампсии у беременных с сахарным диабетом 1 и 2 типов
RU2767912C1 (ru) * 2021-02-12 2022-03-22 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт акушерства, гинекологии и репродуктологии имени Д.О. Отта" Способ прогнозирования риска развития преэклампсии у беременных с различными типами сахарного диабета
WO2024099769A1 (fr) * 2022-11-10 2024-05-16 Metabolomic Diagnostics Limited Procédé de prédiction précoce du risque de pré-éclampsie avant terme dans des cohortes de population spécifiques
CN115575646B (zh) * 2022-11-21 2023-04-28 四川大学华西医院 一种代谢标志物组在制备预测癫痫发作的试剂盒中的用途

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
GB8331514D0 (en) 1983-11-25 1984-01-04 Janssen Pharmaceutica Nv Visualization method
US5514602A (en) 1986-06-09 1996-05-07 Ortho Diagnostic Systems, Inc. Method of producing a metal sol reagent containing colloidal metal particles
US5120643A (en) 1987-07-13 1992-06-09 Abbott Laboratories Process for immunochromatography with colloidal particles
US4853335A (en) 1987-09-28 1989-08-01 Olsen Duane A Colloidal gold particle concentration immunoassay
US4859612A (en) 1987-10-07 1989-08-22 Hygeia Sciences, Inc. Metal sol capture immunoassay procedure, kit for use therewith and captured metal containing composite
GB8800702D0 (en) 1988-01-13 1988-02-10 Nycomed As Test method & reagent kit therefor
US5202267A (en) 1988-04-04 1993-04-13 Hygeia Sciences, Inc. Sol capture immunoassay kit and procedure
US4995402A (en) 1988-10-12 1991-02-26 Thorne, Smith, Astill Technologies, Inc. Medical droplet whole blood and like monitoring
US5079172A (en) 1988-11-04 1992-01-07 Board Of Trustees Operating Michigan State University Method for detecting the presence of antibodies using gold-labeled antibodies and test kit
US5141850A (en) 1990-02-07 1992-08-25 Hygeia Sciences, Inc. Porous strip form assay device method
US5270163A (en) 1990-06-11 1993-12-14 University Research Corporation Methods for identifying nucleic acid ligands
US6027944A (en) 1990-11-22 2000-02-22 Applied Research Systems Ars Holding Nv Capillary-fill biosensor device comprising a calibration zone
US5726010A (en) 1991-07-31 1998-03-10 Idexx Laboratories, Inc. Reversible flow chromatographic binding assay
US6206829B1 (en) 1996-07-12 2001-03-27 First Opinion Corporation Computerized medical diagnostic and treatment advice system including network access
US6107045A (en) 1994-06-30 2000-08-22 Oklahoma Medical Research Foundation Antibodies to lipoproteins and apolipoproteins and methods of use thereof
AU6248796A (en) 1995-05-19 1996-11-29 Universal Health-Watch, Inc. Rapid self-contained assay format
US5681775A (en) 1995-11-15 1997-10-28 International Business Machines Corporation Soi fabrication process
US6001658A (en) 1996-09-13 1999-12-14 Diagnostic Chemicals Limited Test strip apparatus and method for determining presence of analyte in a fluid sample
US6511814B1 (en) 1999-03-26 2003-01-28 Idexx Laboratories, Inc. Method and device for detecting analytes in fluids
US6974706B1 (en) 2003-01-16 2005-12-13 University Of Florida Research Foundation, Inc. Application of biosensors for diagnosis and treatment of disease
AU1924101A (en) * 1999-11-22 2001-06-04 Human Genome Sciences, Inc. Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies
US7361473B2 (en) * 2001-05-04 2008-04-22 Biosite, Incorporated Diagnostic markers of acute coronary syndrome and methods of use thereof
US20030109067A1 (en) 2001-12-06 2003-06-12 Immunetech, Inc. Homogeneous immunoassays for multiple allergens
OA12890A (en) * 2002-07-19 2006-10-13 Beth Israel Hospital Methods of diagnosing and treating pre-eclampsia or eclampsia.
EP1815007A4 (fr) 2004-11-15 2011-10-19 Univ North Dakota Procédé pour incorporer un seul atome d'oxygène dans des peptides digérés au moyen des peptidases
WO2007030889A1 (fr) * 2005-09-15 2007-03-22 Victor Voroteliak Methode de diagnostic de l'eclampsisme
GB0600916D0 (en) * 2006-01-17 2006-02-22 Perkinelmer Instr Las Inc detecting and predicting pre-eclampsia
CN101063677B (zh) * 2006-04-30 2012-07-25 安徽省生物医学研究所 一种预测妊娠不良结局发生风险的试剂盒
US7749773B2 (en) 2006-10-11 2010-07-06 Day Alan R Device for detection of molecules in biological fluids
EP2038431A1 (fr) * 2007-02-01 2009-03-25 Diagnostic Technologies Ltd. Procédé pour déterminer un risque d'éclampsisme
EP3109322A1 (fr) * 2008-01-25 2016-12-28 Wallac Oy Procédés de détermination du risque de complications prénatales
US20100016173A1 (en) 2008-01-30 2010-01-21 Proteogenix, Inc. Maternal serum biomarkers for detection of pre-eclampsia
WO2009108073A1 (fr) 2008-02-28 2009-09-03 Auckland Uniservices Limited Biomarqueurs pour la prédiction d’un éclampsisme et/ou d’une maladie cardiovasculaire
WO2010059952A1 (fr) * 2008-11-20 2010-05-27 Perkinelmer Health Sciences, Inc. Procédé pour déterminer le risque d’éclampsie utilisant les marqueurs pigf-2 et pigf-3
KR101070247B1 (ko) * 2009-01-30 2011-10-06 건국대학교 산학협력단 프로테오믹스기법을 이용한 임신중독 특이 표지 단백질 및 진단방법
CA2793487A1 (fr) * 2010-04-13 2011-10-20 Pronota N.V. Biomarqueurs de troubles lies a l'hypertension pendant la grossesse

Also Published As

Publication number Publication date
US20140349881A1 (en) 2014-11-27
ZA201404319B (en) 2015-06-24
CN104136924B (zh) 2018-05-29
WO2013087887A2 (fr) 2013-06-20
WO2013087887A3 (fr) 2013-10-24
AU2012351504B2 (en) 2018-01-04
AU2012351504A1 (en) 2014-08-07
CN104136924A (zh) 2014-11-05
EP2791683A2 (fr) 2014-10-22
RU2673074C2 (ru) 2018-11-22
EP2791683B1 (fr) 2017-11-15
RU2014128845A (ru) 2016-02-10
BR112014014456A2 (pt) 2018-09-25
CA2859295A1 (fr) 2013-06-20
AU2012351504C1 (en) 2018-04-26

Similar Documents

Publication Publication Date Title
IN2014CN04326A (fr)
WO2012076553A3 (fr) Biomarqueurs et paramètres des troubles d'hypertension de la grossesse
WO2011128357A3 (fr) Biomarqueurs de troubles liés à l'hypertension pendant la grossesse
GB201021289D0 (en) Novel biomarkers for a prediction of the outcome of an immunotherapy against cancer
WO2013083781A3 (fr) Biomarqueurs et panneaux d'essai utiles dans des conditions inflammatoires systémiques
MX2019015159A (es) Composiciones, metodos y usos para asistir en el diagnostico, pronostico y tratamiento de la fibrosis pulmonar idiopatica.
WO2014028884A3 (fr) Diagnostic du cancer au moyen de biomarqueurs
EP2678682A4 (fr) Panel de marqueurs biologiques, procédés de diagnostic et nécessaires d'essais pour le cancer de l'ovaire
EA201390149A1 (ru) Способы выявления заболевания или патологических состояний с использованием фагоцитарных клеток
EP2817617A4 (fr) Dispositifs, méthodes et kits de test pour dosage d'analyte électronique
MX358541B (es) Metodos para predecir el riesgo de desarrollar hipertension.
WO2013066369A3 (fr) Procédés de détection de maladie du greffon contre l'hôte
MX2015010174A (es) Herramientas de diagnostico para predecir la presentacion de preeclampsia.
EA201690213A1 (ru) Композиции и способ лечения связанных с комплементом состояний
EA201500080A1 (ru) Способ in vitro диагностирования и мониторинга рака
WO2013153461A3 (fr) Biomarqueurs salivaires spécifiques pour la détection de risques, le diagnostic précoce, le pronostic et la surveillance de la maladie d'alzheimer et de la maladie de parkinson
WO2014209905A3 (fr) Méthodes et compositions destinées à détecter et à diagnostiquer des maladies et des affections
MX2016001719A (es) Metodos y equipos para predecir el riesgo de tener una enfermedad o evento cardiovascular.
NZ630421A (en) Biomarkers predictive for clinical response for glatiramer acetate
WO2012164525A3 (fr) Biomarqueurs de vieillissement
WO2011130647A3 (fr) Compositions et méthodes pour la caractérisation d'une myopathie
GB201101400D0 (en) Detection method
WO2012139051A3 (fr) Biomarqueurs d'auto-anticorps pour néphropathie iga
WO2012004371A3 (fr) Quiescine q6 utilisée en tant que biomarqueur de troubles hypertensifs de la grossesse
EP3045916A4 (fr) Trousse et méthode de diagnostic, de pronostic ou de surveillance d'une maladie du foie par mesure de la quantité d'ast